Genzyme Corp. has expanded its European presence indiagnostic products and services by signing an agreement withLuc Van den Brande, the prime minister of Flanders, Belgium,to open an office in Leuven.

"Flanders has been traditionally renowned for innovativeresearch in biotechnology through its extensive network ofacademic research institutions," commented Erik Tambuyzer,vice president, diagnostic business development, Europe, who isestablishing the new European office for the Cambridge, Mass.,company (NASDAQ:GENZ).

(c) 1997 American Health Consultants. All rights reserved.